ESR1 and breast cancer: The induction of well characterized TGF-β target genes, including p15INK4B, CTGF, and PAI-1, was also found to be abrogated in a second ER-positive, luminal breast cancer cell line, ZR-75-1, when HER-2 is overexpressed (Fig. 3).